Endeavor Clinical Trials, LLC.

San Antonio, Texas 78240

0 studies enrolling now · 20 studies all time

What they study most

Analgesia, Anesthesia, Bunions, COVID-19, Chronic Kidney Disease, Diabetic Neuropathies, Fatty Liver Disease, General Anesthesia, Healthy, Kidney Diseases, Kidney Failure, Kidney Injury

Studies at this site

• Dose-Escalation Study of HTX-034 Following Bunionectomy — Completed
• Study of Post-Herniorrhaphy Non-opioid MMA Regimens — Completed
• Phase 2 Bunionectomy HTX-011 Administration Study — Completed
• Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen — Completed
• Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People — Completed
• Study Assessing Pain Relief After Replacement of the Knee — Completed
• Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery — Completed
• Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery — Completed
• Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) — Completed
• A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795 — Completed
• Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD — Completed
• Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects — Completed
• A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE — Completed
• A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401. — Status unconfirmed
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy — Completed
• A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease — Completed